Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (421-430 of 651) with videos related to

Pageof 66
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 30, 2010
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Darren W Engers, Patrick R Gentry, Richard Williams, et al.
World Journal of Transplantation|March 19, 2025
Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre studyMatthew G Garas, Luis Calzadilla-Bertot, Briohny W Smith, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Science Signaling|December 5, 2019
Biased M<sub>1</sub> receptor-positive allosteric modulators reveal role of phospholipase D in M<sub>1</sub>-dependent rodent cortical plasticitySean P Moran, Zixiu Xiang, Catherine A Doyle, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu<sub>7</sub> Positive Allosteric Modulator Tool CompoundCarson W Reed, Jacob J Kalbfleisch, Madison J Wong, et al.
Molecular Psychiatry|March 16, 2025
Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndromeFederica Giona, Stefania Beretta, Antonio Zippo, et al.
ACS Bio & Med Chem Au|April 27, 2023
Discovery of "Molecular Switches" within a Series of mGlu<sub>5</sub> Allosteric Ligands Driven by a "Magic Methyl" Effect Affording Both PAMs and NAMs with <i>In Vivo</i> Activity, Derived from an M<sub>1</sub> PAM ChemotypeLisa Barbaro, Alice L Rodriguez, Ashlyn N Blevins, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2019
Surveying heterocycles as amide bioisosteres within a series of mGlu<sub>7</sub> NAMs: Discovery of VU6019278Carson W Reed, Jordan P Washecheck, Marc C Quitlag, et al.
Pageof 66

Showing results (421-430 of 651) with videos related to

Sort By:
Pageof 66
Bioorganic & Medicinal Chemistry Letters|July 30, 2010
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Darren W Engers, Patrick R Gentry, Richard Williams, et al.
World Journal of Transplantation|March 19, 2025
Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre studyMatthew G Garas, Luis Calzadilla-Bertot, Briohny W Smith, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Science Signaling|December 5, 2019
Biased M<sub>1</sub> receptor-positive allosteric modulators reveal role of phospholipase D in M<sub>1</sub>-dependent rodent cortical plasticitySean P Moran, Zixiu Xiang, Catherine A Doyle, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu<sub>7</sub> Positive Allosteric Modulator Tool CompoundCarson W Reed, Jacob J Kalbfleisch, Madison J Wong, et al.
Molecular Psychiatry|March 16, 2025
Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndromeFederica Giona, Stefania Beretta, Antonio Zippo, et al.
ACS Bio & Med Chem Au|April 27, 2023
Discovery of "Molecular Switches" within a Series of mGlu<sub>5</sub> Allosteric Ligands Driven by a "Magic Methyl" Effect Affording Both PAMs and NAMs with <i>In Vivo</i> Activity, Derived from an M<sub>1</sub> PAM ChemotypeLisa Barbaro, Alice L Rodriguez, Ashlyn N Blevins, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2019
Surveying heterocycles as amide bioisosteres within a series of mGlu<sub>7</sub> NAMs: Discovery of VU6019278Carson W Reed, Jordan P Washecheck, Marc C Quitlag, et al.
Pageof 66